Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mathijs Scholtes"'
Autor:
Mathijs Scholtes, Maryam Akbarzadeh, Ellen Zwarthoff, Joost Boormans, Tokameh Mahmoudi, Tahlita Zuiverloon
Publikováno v:
Applied Sciences, Vol 10, Iss 20, p 7102 (2020)
The recommended treatment for metastatic urothelial carcinoma (mUC) patients is platinum-based chemotherapy. Although initial response rates are moderate, the vast majority of patients experience a relapse due to chemoresistance and eventually succum
Externí odkaz:
https://doaj.org/article/956f0a9e5e26475fa7e2ca09c559d910
Autor:
Tahlita C.M. Zuiverloon, Paul C.M.S. Verhagen, Mathijs Scholtes, Astrid A M van der Veldt, Iris G. Iflé, Arnout R. Alberts
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 2832, p 2832 (2021)
International Journal of Molecular Sciences
International Journal of Molecular Sciences
Treatment of patients with urothelial carcinoma (UC) of the bladder or renal cancer has changed significantly during recent years and efforts towards biomarker-directed therapy are being investigated. Immune checkpoint inhibition (ICI) or fibroblast
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe7d9810b4f5af83159dff0487ecf7a7
http://www.scopus.com/inward/record.url?scp=85102339955&partnerID=8YFLogxK
http://www.scopus.com/inward/record.url?scp=85102339955&partnerID=8YFLogxK
Publikováno v:
Journal of Urology. 207
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bddd4532837c1e9eee753d7e1290ca7e
https://doi.org/10.1097/ju.0000000000002630.05
https://doi.org/10.1097/ju.0000000000002630.05
Autor:
Robert T. Jones, Andrew Goodspeed, Saswat Mohapatra, Lily Elizabeth Feldman, Mathijs Scholtes, Hedvig Vekony, Annie Jean, Charlene B. Tilton, Michael V. Orman, Cailin Deiter, Nathaniel Xander, Stephanie Araki, Molishree Joshi, Mahmood Javaid, Eric T. Clambey, Ryan Layer, Teemu D. Laajala, Sarah Parker, Tahlita Zuiverloon, Dan Theodorescu, James C. Costello
Despite routine platinum-based chemotherapeutic use in cancer treatment, there remains a need to improve efficacy and patient selection. Using multi-omic assessment of cisplatin responsive and resistant human bladder cancer cell lines and whole-genom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::83a8758e02f98a7d486b5a2a7802c45e
https://doi.org/10.1101/2021.03.04.433676
https://doi.org/10.1101/2021.03.04.433676
Autor:
Tahlita C.M. Zuiverloon, Ellen C. Zwarthoff, Mathijs Scholtes, Maryam Akbarzadeh, Tokameh Mahmoudi, Joost L. Boormans
Publikováno v:
Applied Sciences, Vol 10, Iss 7102, p 7102 (2020)
Applied Sciences-Basel, 10(20):7102
Applied Sciences-Basel, 10(20):7102
The recommended treatment for metastatic urothelial carcinoma (mUC) patients is platinum-based chemotherapy. Although initial response rates are moderate, the vast majority of patients experience a relapse due to chemoresistance and eventually succum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27e9a499e6c15d28583b70eeaefb8813
https://pure.eur.nl/en/publications/18ea2c06-2a52-45a3-abbd-48469f407ca8
https://pure.eur.nl/en/publications/18ea2c06-2a52-45a3-abbd-48469f407ca8